Teladoc Q2 top line up 38%, shares down 3% after hours as losses continue

Teladoc (NYSE:TDOC) Q2 results ($M): Revenues: 130.3 (+37.7%); Subscription Access Fees: 111.2 (+39.3%).

Net loss: (29.3) (-16.7%); loss/share: (0.41) (-2.5%).

Cash flow ops (6 mo.): (1.7) (+90.3%).

Total visits: 908K (+70.4%).

Q3 guidance: Revenue: $135M – 138M; non-GAAP EBITDA: $7M – 9M; loss/share: ($0.42 – 0.40).

2019 guidance: Revenue: $538M – 545M from $535M – 545M; non-GAAP EBITDA: $27M – 33M from $25M – 35M; loss/share: ($1.60 – 1.52) from ($1.66 – 1.52).

Shares down 3% after hours.

Previously: Teladoc Health EPS in-line, beats on revenue (July 31)

https://seekingalpha.com/news/3484703-teladoc-q2-top-line-38-percent-shares-3-percent-hours-losses-continue